STOCK TITAN

[Form 4] Cardinal Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Stephen M. Mason, an officer of Cardinal Health, Inc. (CAH), reported a non-cash acquisition on 08/12/2025. The filing shows 54,537 performance share units acquired that, per the explanatory note, will settle into common shares on August 15, 2025 at an effective price of $0. After this award, the report lists 89,514 shares beneficially owned following the transaction. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, James E. Barnett, on 08/12/2025. The filing identifies the reporting person as an officer with title shown as CEO, GMPD Segment.

Stephen M. Mason, dirigente di Cardinal Health, Inc. (CAH), ha comunicato un'acquisizione non in contanti in data 12 agosto 2025. La segnalazione indica l'acquisizione di 54.537 unità di azioni legate alla performance che, come specificato nella nota esplicativa, saranno convertite in azioni ordinarie il 15 agosto 2025 a un prezzo effettivo di $0. Dopo questo premio, il rapporto riporta la detenzione effettiva di 89.514 azioni a seguito della transazione. Il Form 4 è stato firmato per conto del soggetto segnalante dall'avvocato-in-fatto James E. Barnett in data 12 agosto 2025. La comunicazione identifica il soggetto come dirigente con il titolo di CEO, GMPD Segment.

Stephen M. Mason, directivo de Cardinal Health, Inc. (CAH), notificó una adquisición no monetaria el 12 de agosto de 2025. El informe recoge la obtención de 54.537 unidades de acciones por desempeño que, según la nota explicativa, se convertirán en acciones ordinarias el 15 de agosto de 2025 a un precio efectivo de $0. Tras esta adjudicación, el informe refleja la propiedad beneficiaria de 89.514 acciones como resultado de la transacción. El Form 4 fue firmado en nombre de la persona que informa por apoderado, James E. Barnett, el 12 de agosto de 2025. La notificación identifica a la persona informante como directivo con el cargo de CEO, GMPD Segment.

Stephen M. Mason은 Cardinal Health, Inc.(CAH)의 임원으로서 2025년 8월 12일 비현금 취득을 보고했습니다. 제출서류에는 54,537개의 성과 기준 주식 단위가 취득된 것으로 나타나며, 설명에 따르면 이 단위들은 2025년 8월 15일 보통주로 지급되고 실효 가격은 $0입니다. 이번 수여 후 보고서에는 거래 이후 실질적으로 보유한 주식이 89,514주로 기재되어 있습니다. Form 4는 대리권을 가진 법정대리인 James E. Barnett2025년 8월 12일에 보고인을 대신해 서명했습니다. 제출서류는 보고인을 임원으로 식별하며 직함은 CEO, GMPD Segment로 표기되어 있습니다.

Stephen M. Mason, cadre de Cardinal Health, Inc. (CAH), a déclaré une acquisition non monétaire le 12 août 2025. Le document indique l'acquisition de 54 537 unités d'actions liées à la performance qui, selon la note explicative, seront converties en actions ordinaires le 15 août 2025 pour un prix effectif de 0 $. Après cette attribution, le rapport fait état de la détention effective de 89 514 actions à la suite de la transaction. Le formulaire Form 4 a été signé pour le compte de la personne déclarante par un mandataire, James E. Barnett, le 12 août 2025. Le dossier identifie la personne déclarante comme dirigeant, avec le titre CEO, GMPD Segment.

Stephen M. Mason, ein leitender Angestellter von Cardinal Health, Inc. (CAH), meldete am 12. August 2025 eine nicht zahlungswirksame Erwerbung. Die Einreichung weist den Erwerb von 54.537 Performance-Share-Einheiten aus, die laut erläuternder Anmerkung am 15. August 2025 in Stammaktien umgewandelt werden und einen effektiven Preis von $0 haben. Nach dieser Zuteilung werden in der Meldung 89.514 wirtschaftlich gehaltene Aktien nach der Transaktion angegeben. Das Form 4 wurde im Namen der meldenden Person am 12. August 2025 vom Bevollmächtigten James E. Barnett unterschrieben. Die Meldung identifiziert die meldende Person als Führungskraft mit dem Titel CEO, GMPD Segment.

Positive
  • Acquired 54,537 performance share units that will settle into common shares on August 15, 2025, increasing reported beneficial ownership to 89,514 shares
  • Timely Section 16 disclosure filed and signed (via attorney-in-fact) on 08/12/2025
Negative
  • None.

Insights

TL;DR: Routine, non-cash PSU award increases an officer's ownership; governance impact is standard and not immediately market-moving.

The Form 4 documents an award of 54,537 performance share units that will settle into common shares on August 15, 2025. As a non-cash equity award, this changes beneficial ownership metrics but does not represent a market transaction or cash inflow/outflow. The filing was executed by an attorney-in-fact, which is common for insider reporting. From a governance perspective, the disclosure is timely and follows Section 16 reporting requirements; it does not, by itself, indicate any governance concerns.

TL;DR: Insider grant increases reported stake to 89,514 shares; the award settles later and carries no immediate cash impact.

The entry records 54,537 performance share units acquired on 08/12/2025 that will settle on August 15, 2025 and are shown at $0 price, consistent with compensation-based PSU awards. Beneficial ownership following the reported transaction is 89,514 shares. Because this is a compensation settlement rather than an open-market purchase or sale, it is unlikely to be material to Cardinal Health's public float or near-term share supply. The disclosure is precise about dates and settlement.

Stephen M. Mason, dirigente di Cardinal Health, Inc. (CAH), ha comunicato un'acquisizione non in contanti in data 12 agosto 2025. La segnalazione indica l'acquisizione di 54.537 unità di azioni legate alla performance che, come specificato nella nota esplicativa, saranno convertite in azioni ordinarie il 15 agosto 2025 a un prezzo effettivo di $0. Dopo questo premio, il rapporto riporta la detenzione effettiva di 89.514 azioni a seguito della transazione. Il Form 4 è stato firmato per conto del soggetto segnalante dall'avvocato-in-fatto James E. Barnett in data 12 agosto 2025. La comunicazione identifica il soggetto come dirigente con il titolo di CEO, GMPD Segment.

Stephen M. Mason, directivo de Cardinal Health, Inc. (CAH), notificó una adquisición no monetaria el 12 de agosto de 2025. El informe recoge la obtención de 54.537 unidades de acciones por desempeño que, según la nota explicativa, se convertirán en acciones ordinarias el 15 de agosto de 2025 a un precio efectivo de $0. Tras esta adjudicación, el informe refleja la propiedad beneficiaria de 89.514 acciones como resultado de la transacción. El Form 4 fue firmado en nombre de la persona que informa por apoderado, James E. Barnett, el 12 de agosto de 2025. La notificación identifica a la persona informante como directivo con el cargo de CEO, GMPD Segment.

Stephen M. Mason은 Cardinal Health, Inc.(CAH)의 임원으로서 2025년 8월 12일 비현금 취득을 보고했습니다. 제출서류에는 54,537개의 성과 기준 주식 단위가 취득된 것으로 나타나며, 설명에 따르면 이 단위들은 2025년 8월 15일 보통주로 지급되고 실효 가격은 $0입니다. 이번 수여 후 보고서에는 거래 이후 실질적으로 보유한 주식이 89,514주로 기재되어 있습니다. Form 4는 대리권을 가진 법정대리인 James E. Barnett2025년 8월 12일에 보고인을 대신해 서명했습니다. 제출서류는 보고인을 임원으로 식별하며 직함은 CEO, GMPD Segment로 표기되어 있습니다.

Stephen M. Mason, cadre de Cardinal Health, Inc. (CAH), a déclaré une acquisition non monétaire le 12 août 2025. Le document indique l'acquisition de 54 537 unités d'actions liées à la performance qui, selon la note explicative, seront converties en actions ordinaires le 15 août 2025 pour un prix effectif de 0 $. Après cette attribution, le rapport fait état de la détention effective de 89 514 actions à la suite de la transaction. Le formulaire Form 4 a été signé pour le compte de la personne déclarante par un mandataire, James E. Barnett, le 12 août 2025. Le dossier identifie la personne déclarante comme dirigeant, avec le titre CEO, GMPD Segment.

Stephen M. Mason, ein leitender Angestellter von Cardinal Health, Inc. (CAH), meldete am 12. August 2025 eine nicht zahlungswirksame Erwerbung. Die Einreichung weist den Erwerb von 54.537 Performance-Share-Einheiten aus, die laut erläuternder Anmerkung am 15. August 2025 in Stammaktien umgewandelt werden und einen effektiven Preis von $0 haben. Nach dieser Zuteilung werden in der Meldung 89.514 wirtschaftlich gehaltene Aktien nach der Transaktion angegeben. Das Form 4 wurde im Namen der meldenden Person am 12. August 2025 vom Bevollmächtigten James E. Barnett unterschrieben. Die Meldung identifiziert die meldende Person als Führungskraft mit dem Titel CEO, GMPD Segment.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mason Stephen M

(Last) (First) (Middle)
7000 CARDINAL PLACE

(Street)
DUBLIN OH 43017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CEO, GMPD Segment
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/12/2025 A(1) 54,537 A $0 89,514 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects performance share units that will settle on August 15, 2025.
Remarks:
/s/ James E. Barnett, Attorney-in-fact 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stephen M. Mason report on CAH Form 4?

He acquired 54,537 performance share units on 08/12/2025 that will settle into common shares on August 15, 2025, increasing reported beneficial ownership to 89,514 shares.

What is the effective price of the reported transaction on CAH Form 4?

The award is reported at $0, consistent with compensation-based performance share units that will settle into common shares.

When will the performance share units reported for CAH settle into shares?

The explanatory note states settlement will occur on August 15, 2025.

Who signed the Form 4 for the reporting person?

James E. Barnett, Attorney-in-fact, signed the Form 4 on 08/12/2025.

What is Stephen M. Mason's relationship to Cardinal Health in this filing?

The filing identifies him as an officer with the title shown as CEO, GMPD Segment.
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Latest News

CAH Latest SEC Filings

CAH Stock Data

34.92B
237.95M
0.29%
89.15%
2.39%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN